Levent Peskircioglu

Conventional testicular sperm extraction combined with the microdissection technique in nonobstructive azoospermic patients: a prospective comparative study

OBJECTIVE To perform conventional and microdissection testicular sperm extraction (TESE) at the same session and compare their effectiveness. DESIGN Prospective comparative study. SETTING University hospital setting. PATIENT(S) The study included 335 patients with nonobstructive azoospermia. INTERVENTION(S) Microdissection TESE was performed to 77 patient with atrophic testes. An additional 258 patients underwent conventional TESE using three incisions on three quadrants of the testis (upper, middle, and lower). Microdissection TESE was performed by enlarging the middle incision vertically when no spermatozoa could be detected using the conventional technique. MAIN OUTCOME MEASURE(S) Sperm retrieval, fertilization, clinical pregnancy rate (PR), and live birth rate were evaluated. The relation between sperm retrieval rate and FSH level and testis volume was also investigated. RESULT(S) Spermatozoa was detected in 33.7% of patients using conventional TESE. The spermatozoa detected increased to 50.8% using microdissection TESE. The increase was statistically significant. In the primary microdissection TESE group, the surgical retrieval rate was 20.8%. The overall sperm retrieval rate was 43.9%. There was a significant relation between the sperm retrieval rate and testis volume, whereas there was no relation between sperm retrieval rate and FSH levels. The overall fertilization rate, clinical PR, and live birth rate were 57.1%, 50.4%, 36.4%, respectively. CONCLUSION(S) Conventional TESE combined with microdissection TESE can be used in selected patients. Sperm retrieval rate of TESE can be low in patients with atrophic testes.

Evaluation of Erectile Function in Renal Transplant Recipients

RECTILE dysfunction describes the inability to achieve and maintain penile erection sufficient for coitus. Renal insufficiency is a chronic disease during which erectile function deteriorates, however, the etiology of this condition in such patients is multifactorial, involving organic and nonorganic (psychogenic) factors. 1 The condition may result from neuroendocrine disturbance, uremia, hypoxia, and atherosclerosis. 2 Neuroendocrine disturbance is often reversed by renal transplantation, but not by dialysis. 3 Psychological factors may also cause erectile dysfunction in dialysis patients, since approximately one fourth of these individuals are depressed at any given time. 4 Patients often regain potency after transplantation but in some cases, especially second transplantations, erectile function is adversely affected by interference with arterial blood flow. In this study, we evaluated the effect of renal transplantation on erectile function. PATIENTS AND METHODS Information on erectile function was collected by means of a questionnaire given to 65 men who were renal transplant recipients. The patients ranged in age from 20 to 57 years (mean 42.5 years). A second transplantation had been performed in four cases (6%). Posttransplantation follow-up ranged from 2 to 168 months (mean 72 months). A detailed medical history was taken and complete blood count, urinalysis, and a biochemical and endocrinologic blood analysis were routinely performed for all patients. A papaverine test, penile Doppler ultrasonography, cavernosometry, cavernosography, and pudendal angiography were done where indicated. For patients who had no erectile dysfunction before or after renal transplantation, the questionnaire and routine tests completed the evaluation. This group was considered to have experienced no change in erectile function due to renal transplantation. Similarly, no further tests were performed on patients who were afflicted with erectile dysfunction prior to renal transplantation but regained sexual function following transplantation. These patients were defined as the group with improved sexual function. On the other hand, patients with deteriorated erectile function after renal transplantation were evaluated in detail. All underwent a papaverine test involving intracavernous injection of 50 mg of papaverine and observation of response after 30 minutes. The group which experienced full erection after papaverine treatment (papaverine responders) was considered to have nonorganic (psychogenic) erectile dysfunction. Patients who did not respond to papaverine were further evaluated by penile Doppler ultrasonography for vasculogenic impotence. Papaverine-stimulated penile Doppler ultrasound was performed using a 7.5-MHz linear probe. Peak systolic velocities in the cavernous arteries were measured bilaterally. A peak systolic velocity of ,25 cm/s was considered as arterial insufficiency. Patients with arterial insufficiency underwent pudendal angiography, while those with normal penile Doppler ultrasound findings underwent dynamic infusion cavernosometry and cavernosography to assess for suspected veno-occlusive dysfunction. RESULTS Thirty-two patients (49.2%) experienced no alteration in erectile function before or after renal transplantation. Twelve patients (18.4%) said they regained erectile function after renal transplantation. Twenty-one patients (32.3%) with normal erectile function prior to transplantation during the hemodialysis period reported erectile dysfunction after the transplantation, constituting the group which was evaluated further. Seven of these patients were papaverine responders (nonorganic impotence) and benefited from antiserotoninergic treatment. All seven men received 150 mg/d trazodone initially, however, two patients who reported severe side effects with this drug were switched to sertraline at a dose of 50 mg/d. All patients in this group achieved erections sufficient for coitus within 3 months. In three patients, deterioration of erectile function was associated with hyperprolactinemia accompanied by a low testosterone level. A papaverine test was not performed in these cases. Oral testosterone replacement resulted in improved sexual function. Eleven of 21 patients who reported a deterioration in erectile function after transplantation did not respond to papaverine. These individuals were considered to have vasculogenic impotence. According to penile Doppler ultrasound, nine of these men had arterial insufficiency, while two had normal peak systolic velocities in their cavernous arteries, indicating no arterial insufficiency. These two patients underwent cavernosometry and cavernosography, which confirmed veno-occlusive dysfunction. They were treated with deep dorsal vein embolization using n-butyl cyanoacrylate, and regained satisfactory erections within 3 months, at which time control cavernosometry was normal.

Anterior urethral valve as a cause of end-stage renal disease.

Abstract Although posterior urethral valves are predominant as a cause of obstructive uropathy in children, anterior urethral valves may also appear as the underlying etiologic factor in end‐stage renal disease that results from obstruction. Two cases are presented of anterior urethral valve patients that were admitted with end‐stage renal disease. The first case was successfully treated with diverticulectomy and urethral reconstruction in preparation for renal transplantation. The second case, however, had been on cystostomy drainage for 6 years and also had a contracted bladder. A more extensive lower urinary tract reconstruction was delayed. Children with poor stream and recurrent infections should be evaluated carefully and anterior urethral valve or diverticula should be considered in differential diagnosis of obstructive lesions.

Do Changes in a High Serum Prostate-Specific Antigen Level and the Free/Total Prostate-Specific Antigen Ratio after Antibiotic Treatment Rule Out Biopsy and the Suspicion of Cancer?

Objectives: To evaluate the impact of antibiotic treatment in patients with higher-than-normal prostate-specific antigen (PSA) levels in terms of changes both in total PSA and free/total (f/t) PSA ratios. Materials and Methods: Serum PSA and f/t PSA changes after antibiotic treatment in 85 patients with normal digital rectal examination but elevated age-adjusted serum PSA levels were evaluated with relevance to biopsy results. Results: Serum PSA levels decreased after antibiotic treatment in 47 of 85 patients. The f/t PSA ratio decreased or remained unchanged in 21 and increased in 26 of these 47 cases. Cancer detection rate in the former group was 52.4% (11/21), while it was 7.7% (2/26) in the latter (p = 0.002). There were 38 patients with increased PSA levels after antibiotics. The f/t PSA ratios decreased or remained unchanged in 20 and increased in 18 of these 38 cases. Cancer detection rates were 55% (11/20) in the former and 16.7% (3/18) in the latter group (p = 0.003). Conclusions: The PSA and f/t PSA levels may change with long-term antibiotic treatment in patients with elevated PSA values. The f/t PSA ratio rather than total PSA appears to be more helpful in suggesting prostate cancer in these cases.

Neurofibroma of the bladder wall in von Recklinghausen's disease

Abstract Neurofibromatosis, or von Recklinghausens disease, is an autosomal dominant disease with multiple neurofibroma and café‐au‐lait spots. However, neurofibroma in the bladder wall is a rare condition in von Recklinghausens disease. A 31‐year‐old man with neurogenic voiding dysfunction due to sacral meningocele and acute urinary retention with neurofibroma of the bladder wall is presented with detailed radiologic evaluation. Patients with von Recklinghausens disease should be carefully evaluated if urological symptoms exist.

Ureteroscopic treatment of proximal ureter stones with the aid of an antegrade occlusion balloon catheter

Purpose: To define the role of an antegrade occlusion balloon catheter in preventing migration of proximal ureteral stones to the dilated proximal ureter during endoscopic treatment. Material and Methods: An occlusion balloon catheter was used in 8 of 21 patients with proximal ureteral stones who underwent ureterorenoscopy. Five of the eight patients had solitary kidneys admitting with anuria and had percutaneous nephrostomy. In the other three patients, percutaneous nephrostomy and occlusion balloon catheters were placed a day before the procedure, since these patients had total obstruction and massive dilatation of the proximal ureter and renal collecting system. The balloons of occlusion catheters were inflated with 1 ml of sterile saline proximal to the stones just before ureterorenoscopy. Results: All stones could be reached by ureterorenoscopy and treated successfully with the aid of an ultrasonic lithotripter, and no stone migration to the upper dilated collecting system was observed. Just after the operation, while the patient was still lying on the operation table, the occlusion catheter was removed. The nephrostomy catheter was removed a day later. All patients were totally stone-free after the procedures. Conclusion: Occlusion balloon catheters increase the ureteroscopic treatment success rate in proximal ureter stones. This should be kept in mind especially when dilatation of the proximal collecting system is prominent and in cases with unsuccessful previous intervention with a retrograde stone cone catheter.

The Effect of Topical Synthetic Prostaglandin E1 (Misoprostol) on Clitoral Hemodynamics

INTRODUCTION Genital blood flow plays an important role on female sexual function. Measures that increase genital blood flow may be a therapeutic approach for female sexual dysfunction. AIM This study aims to show the effect of topical misoprostol, a synthetic prostaglandin, on clitoral blood flow. METHODS Seventeen volunteers with female sexual dysfunction on the basis of female sexual function index scores were included in the study. All women were premenopausal and within their sexually active ages. Hormonal profiles were also normal. Those with suspected pregnancy, history of pelvic or vaginal surgery or radiotherapy, and diabetes or hypertension were excluded. Female sexual function index scores were determined. Clitoral peak systolic velocity (PSV) and clitoral artery diameter of all women were measured by using Doppler ultrasound. The measurements were done on two occasions as before and after placebo in one session and before and after 100 µg of misoprostol in another. This is a double-blind study where the patient and the ultrasonographist were unaware of either placebo or active drug has been applied before measurements. MAIN OUTCOME MEASURES Clitoral artery diameter and peak systolic velocity. RESULTS Misoprostol caused a significant increase in clitoral artery PSV compared to basal level (P = 0.0001), while changes in clitoral artery PSV with placebo remained insignificant. Remarkably, misoprostol caused 118.3% increase in clitoral artery PSV and 47.5% increase in clitoral artery diameter when compared to basal levels. No side effects were observed. CONCLUSION Topical misoprostol can significantly increase clitoral blood flow without any unwanted effects and this finding may be promising for future investigations with relevance to female sexual dysfunction.

A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency.

Background Vardenafil, a selective phosphodiesterase 5 (PDE5) inhibitor, may affect nasal patency because of its adverse-effect profile. This double-blind, placebo-controlled, randomized clinical study sought to assess the effect of vardenafil on nasal patency in patients at a university hospital. Methods Nasal patency was assessed using a visual analog score and by measuring the minimum cross-sectional areas (MCAs) and nasal cavity volumes with acoustic rhinometry in 14 subjects before and after administration of vardenafil. Measurements were repeated after administration of a local decongestant spray. Results There was no statistically significant difference between the nasal cavity volumes, MCA, and visual analog scale (VAS) scores before and after the administration of placebo. However, there was a significant increase in the nasal cavity volumes, MCAs, and VAS scores after application of the local decongestant. A significant correlation was found between MCAs and VAS scores (r = 0.96; p < 0.001). After administration of vardenafil, there was a significant increase in the degree of subjective sense of nasal obstruction as measured by VAS scores. Total nasal volumes showed a significant decrease (p < 0.05). The congestion effect induced by the vardenafil was reversed after application of the local decongestant spray, and a significant increase in cross-sectional areas was noted. In the vardenafil group, a significant increase in MCA, total volume, and VAS scores was observed after application of the local decongestant (p < 0.05). Conclusion Objective and subjective nasal obstruction after administration of vardenafil was significantly higher in this study than in previously reported studies. The effect of congestion can be reversed by local decongestants. The role of PDE5 inhibitors in nasal physiology merits additional investigation.

Endoscopic treatment of complete bladder neck obstruction by transurethral Seldinger technique

Abstract Bladder neck contracture is usually a complication of prostatectomy and the treatment of choice in such a condition should be endoscopic surgery. However, in a few patients the bladder neck may be completely obstructed preventing retrograde access into the bladder. A case is presented of complete bladder neck obstruction occurring after transurethral resection of prostate, which was treated after an access was provided by using transurethral Seldinger technique.

Venous leg symptoms in patients with varicocele: A multicenter assessment study (VEIN-TURKEY study)

Objective The aim of this study is to evaluate chronic venous disease symptoms by using the Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms (VEINES-QoL/Sym) questionnaire in varicocele patients. Material and methods The study was designed as a prospective, case controlled study and conducted in four hospitals from Turkey. A total of 600 patients who admitted to urology outpatient clinic were enrolled to the study. After the exclusion of 44 patients who do not match the inclusion criteria, the remaining 556 patients were examined for the presence and grade of varicocele and subsequently examined clinically for the presence of chronic venous disease findings. Finally, patients were asked to answer the VEINES-Sym questionnaire consisting of 10 items. All patients’ demographic parameters, cardiovascular risk factors, other co-morbid diseases and drug usage were noted. Results Patients were classified into two groups: varicocele (+) group (n = 269) and varicocele (−) group (n = 287). VEINES-Sym scores of varicocele patients were lower compared to patients without varicocele (41.41 ± 5.21, 43.19 ± 3.22, respectively, p < 0.001). Grades of varicocele significantly but inversely correlated with VEINES-Sym score (r = 0, −206, p = 0.001). Logistic regression analysis revealed that presence of varicocele irrespective of grading significantly and independently associated with the presence of aching (odds ratio: 2.054, 95% confidence interval: 1.265–3.338, p = 0.004) and throbbing (odds ratio: 2.586, 95% confidence interval: 1.353–4.943, p = 0.004). Conclusion Varicocele patients have lower VEINES-Sym scores compared to patients without varicocele and this finding is inversely correlated with the degree of the varicocele. This association supports the hypothesis that there may be a systemic vessel wall abnormality in venous disease patients. Patients with symptoms related to vascular dilatation in any territory may deserve to be assessed systematically with the support of further clinical studies.